New Delhi, July 20 -- Manipal Hospitals and quick-commerce firm Zepto are taking a cut in their valuations in their planned initial public offerings while private equity firm CX Partners is looking to... Read More
New Delhi, July 17 -- Global investor LetterOne has tapped a former pension fund executive to lead its investment programme in India, while Zurich Insurance is reportedly considering buying out Kotak ... Read More
New Delhi, July 16 -- MakeMyTrip India is gearing for a confidential filing for an initial public offering (IPO), New York-headquartered Brookfield's renewable energy portfolio in Bikaner, Rajasthan h... Read More
New Delhi, July 16 -- Indian private equity firm True North and Singaporean state investment firm Temasek are exiting a healthcare portfolio company with poor returns on their bet as the company has f... Read More
New Delhi, July 15 -- IDBI Bank is set to secure an investment from Canada's Fairfax Holdings, while Kenro Capital is in the final stages of closing its secondaries fund. Meanwhile, Dawaa Dost, Ultra... Read More
New Delhi, July 14 -- Indira IVF, India's largest fertility chain operator, has appointed the former chief executive officer of Verlinvest-backed Ferty9 Fertility Center to lead the company's growth a... Read More
New Delhi, July 14 -- Canadian investment firm Fairfax may increase its bid to acquire IDBI Bank, with the Indian government set to accept the offer, while multiple private equity firms are looking to... Read More
New Delhi, July 13 -- Private equity firm Carlyle is set to buy a controlling stake in defence technology firm Micropack while Invus Group is closing to picking up a minority stake in Popo Ventures an... Read More
New Delhi, July 13 -- Emcure Pharmaceuticals Ltd has acquired the remaining stake in its biopharma subsidiary, Gennova Biopharmaceuticals Ltd, taking full ownership of the company. The Mumbai-listed ... Read More
New Delhi, July 10 -- Homegrown private equity firm ChrysCapital's open offer to acquire additional shares of Novartis India Ltd has found no takers as the drugmaker's shares rallied in recent months.... Read More